💨 Abstract
The FDA's vaccine chief, Dr. Vinay Prasad, restricted approval of two COVID-19 vaccines from Novavax and Moderna, limiting them to high-risk individuals. This decision contradicted the recommendations of FDA scientists, who had approved the vaccines for everyone aged 12 and older. Prasad cited falling COVID-19 death and hospitalization rates, as well as potential vaccine side effects, as reasons for the restriction. This move aligns with the stance of Health Secretary Robert F.
Courtesy: WTOP Staff
Suggested
Bailey hit sacrifice fly in 10th to lift Giants over D-backs and snap 4-game losing streak -
Thailand’s new Cabinet members take oaths, including suspended prime minister -
Asian shares mostly higher after US stocks hit another record as Tesla and Nike rally -
Dodgers rally past White Sox in 9th inning; Kershaw reaches 3,000 strikeouts -
South Korea’s leader says trade deal with US remains unclear ahead of Trump’s deadline -
Tibetans in exile wonder: Will the next Dalai Lama be as charismatic as this one? -
Científicos secuencian por primera vez todo el genoma de una persona del antiguo Egipto y hallan una ascendencia sorprendente -
Massachusetts advocates fear Trump’s bill will unravel health safety net in Obamacare’s model state -
Takeaways from AP report on company that sold 200,000 carbon credits to remove CO2 from ocean -
Bangladesh tribunal sentences Hasina to jail for contempt over a claim she had a license to kill -